Skip To Main Content
Niccolò Bartalucci on Muck Rack

Niccolò Bartalucci

As seen in: Color Research & Application, Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Niccolò

Contact Niccolò, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia - Blood Cancer Journal

|
By Niccolò Bartalucci, Francesco Mannelli, Danilo Tarantino, Alessio Enderti, Simone Romagnoli, Daniele Colazzo, Barbara Scappini, Matteo Piccini, Leonardo Signori, Tiziana Ottone, Alfonso Piciocchi, Margherita Vannucchi, Maria Chiara Siciliano, Silvia Orsi, Paola Fazi, Raffaella Santi, Marco Vignetti, Stefania Bortoluzzi, Alberto Bosi, Adriano Venditti, Alessandro Rambaldi, Maria Teresa Voso, Paola Guglielmelli, Alessandro Vannucchi, Giacomo Gianfaldoni, Fiorenza Irushani, Silvia Salmoiraghi, Roberto Boccacci, Alessia Civini
| Nature Verified
Abstract Cytogenetic and genomic profiling of acute myeloid leukemia (AML) guides personalized treatment according to ELN2022 recommendations. However, marked outcome variability persists among cytogenetically normal (CN-) patients, representing an unmet clinical need. We used long-read whole-genome sequencing to interrogate the prognostic significance of structural variations (SVs) in a prospective cohort of 162 intensively treated CN-AML patients.
Open in Who Shared Issue with article?

A Novel, Ruxolitinib‐Sensitive, CCDC6::JAK2 Fusion Gene in a Patient With Atypical, JAK2 Unmutated, Polycythemia Vera‐Like, Myeloproliferative Neoplasm

|
By Niccolò Bartalucci, AOU Careggi, Danilo Tarantino, Giuseppe G. Loscocco
| Wiley Online Library Verified
To the Editor, The majority of patients with classic myeloproliferative neoplasms (MPNs) harbor driver mutations [1] in JAK2 [2], CALR [3], and MPL [4]; a few are “triple negative” or have non-canonical mutations [5]. Outside classical forms, rare genetic abnormalities are described in unique MPN variants, as the category of “Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes” [6, 7].
Open in Who Shared Issue with article?

Correction: A novel approach for highly sensitive and rapid identification of HMGA2 submicroscopic deletions in myeloproliferative neoplasms - Leukemia

|
By Niccolò Bartalucci, Danilo Tarantino, Alessio Enderti, Daniele Colazzo, Paola Guglielmelli
| Nature Verified
Correction to: Leukemia https://doi.org/10.1038/s41375-025-02678-4, published online 14 July 2025 In this article the author’s name Niccolò Bartalucci was incorrectly written as Bartalucci Niccolò. The original article has been corrected.
Open in Who Shared Issue with article?
See all 9 articles